Australia has published a framework for new CBD regulations as it considers relaxing its narcotics scheduling of cannabidiol to make it available over the counter in […]
In the coming months, the TGA will expand the number of quality audits of medicinal cannabis products imported or supplied under the Special Access Scheme (SAS) […]
A scientific study conducted by Professor Poulas Konstantinos and his team from the Department of Pharmacy at the University of Patras in Greece, and in collaboration […]
Even on a good day, eight-year-old Sophie Martin has hundreds of seizures. When she has a severe seizure, she turns blue and cannot breathe. She has […]
Don’t bring others down! Message from BBS Pharmaceuticals’ CEO, John Dagas regarding the medicinal cannabis industry. “The start of 2020 has seen a number of medicinal […]
“Medicinal cannabis can be the healthcare success story of our lifetime,” says Hugh Hempel, a technology industry veteran turned health care entrepreneur. In this moving talk, […]
The Food and Drug Administration (FDA) has approved a first-of-its-kind human trials study by the Yale School of Medicine in conjunction with CT Pharma that will […]
BBS’s Primary growth strategy is to connect with the export markets. As a leader in the market of medicinal cannabis, BBS is focusing on establishing regional […]